Scientists at Scripps Research, inspired by electric car batteries, have developed a battery-like system that allows them to make potential advancements for the manufacturing of medicines.
As co-leaders of an international collaboration, scientists at Scripps Research have discovered that tethering four antibodies together may be an effective strategy for neutralizing all types of influenza virus known to infect humans.
New insight into how cells sense blood pressure could present better targets for treating hypertension.
Scientists at Scripps Research and their collaborators have created microorganisms that may recapitulate key features of organisms thought to have lived billions of years ago, allowing them to explore questions about how life evolved.
Scientists investigating how the human immune system defends against malaria have uncovered a rare phenomenon: antibodies working together to bind to a vulnerable spot on the parasite.
Predictors of future diabetes and cardiovascular disease for a person with obesity can be found among their body's metabolites.
Benedict Gross, PhD, a professor emeritus of mathematics at Harvard University and former dean of Harvard College, has joined the Board of Directors at Scripps Research.
The prestigious award will support the Cravatt laboratory with $7.8 million over seven years.
Scientists at Scripps Research have discovered the role of an immune system double agent. This molecule, called USP18, can help curtail immune responses, but it can also open the door to bacterial infections, such as harmful listeria and staph infections.
Havran, a professor at Scripps Research and associate dean of the Skaggs Graduate School of Chemical and Biological Sciences, was recently named the 2018 Outstanding Mentor by the Society of Fellows, a postdoctoral organization at Scripps Research.
Two new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not only for Ebola virus, but for other closely related pathogens as well.
Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.
"In humans, being able to tweak levels of TTR degradation could act as a means of stopping TTR toxicity."
The study, published recently in Nature Communications, shows that a molecule in cells, called Rad52, repairs special kinds of damaged DNA that accumulate in some cancers.
New Scripps Research study offers guidance for more effective Ebola vaccines
Expertise encompasses cancer, immunotherapy and regenerative medicine
The research offers another approach for tackling diseases that have been considered "undruggable," including amyotrophic lateral sclerosis (ALS), muscular dystrophy, cystic fibrosis and certain cancers.
“The big takeaway here is that we have a new molecular target linked to alcohol addiction,” says Olivier George, PhD, associate professor at Scripps Research.
Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors.
The microbiome may harbor a gene for drug resistance
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right